The gap between what works and what's marketed comes down to three things: bioavailability, timing, and the specific form of glutathione administered
Statistics All experiments were repeated at least three times independently
In NSCLC Fan et al
The proteins were incubated with 0.67 mg/ml DTNB and 10 U/ml glutathione reductase in 0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt, pH 7.5
However, they can also accumulate due to pollution, radiation, toxins, smoking, or unhealthy lifestyle habits
decades of cosmetic and wound-healing literature No multi-center RCT BPC-157: Limited, Emerging Clinical Evidence 100+ preclinical repair studies Human evidence is thin but real PL-14736 (its clinical-development name) reached abstract-level Phase 1/2 in ulcerative colitis A modern hamstring tendon Phase 2 RCT is recruiting, and an intra-articular knee case series exists Clean early-phase safety